Accrol Group Holdings Plc – Expect Double Digit Revenue Growth

Accrol Group Holdings PLC (LON:ACRL) are the topic of conversation today when DirectorsTalk caught up with Mike Allen, Head of Research at Zeus Capital. Mike shares his thoughts on today’s trading statement from the company, explains his forecast assumptions and shares his view on the current stock valuation.  

See More...

Vertu Motors Plc – Valuation within sector is very compelling

Vertu Motors Plc (LON:VTU) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital caught up with DirectorsTalk. Mike shares his thoughts on how the company has performed, explains the drivers behind the good results, how this has affected the forecast and shares his views on the company stock price and […]

See More...

Xafinity Plc Share price relects quality of revenues

Xafinity Plc (LON:XAF) is the topic of discussion when Robin Savage, Research Director at Zeus Capital talks to DirectorsTalk. Robin explains what the company does, the main points for investors to consider, his thoughts on the current share price and what might move it higher. Xafinity plc is a pensions actuarial, consulting and administration business […]

See More...

SigmaRoc Plc More significant growth initiatives expected

SigmaRoc Plc (LON:SRC) is the topic of discussion when Nick Chalmers Director of Metals and Mining at Zeus Capital caught up with DirectorsTalk to chat about the release of SigmaRoc’s annual results for 2016. Nick explains how the company is looking, how the business has improved since the company took control of Ronez at the start […]

See More...

SigmaRoc Plc First quarter very positive

SigmaRoc Plc (LON:SRC) CEO Max Vermorken catches up with DirectorsTalk to talk a little bit about the company and where it’s headed. Max provides us with an overview of the sector and its dynamics, how the company is positioning itself in the sector, it’s focus, it’s new subsidiary and why its key for the business […]

See More...

Flowtech Fluidpower Could see a really strong share price performance

Flowtech Fluidpower Plc (LON:FLO) is the topic of conversation when Andy Hanson, Equity Research Director at Zeus Capital talks to DirectorsTalk. Andy talks us through the year end results, first quarter update, financial position, his thoughts on how soon we’ll see more acquisitions and how this affects the valuation. Flowtech Fluidpower plc, founded as Flowtech […]

See More...

Inchcape PLC Very good value shares in a unique global business

Inchcape PLC (LON:INCH) are the topic of conversation when Zeus Capital’s head of research Mike Allen caught up with DirectorsTalk. Mike shares his thoughts on the business model, balance sheet, explains the assumptions used when calculating the forecast and what he thinks of the current trading levels. Inchcape Plc is a leading global premium automotive […]

See More...

ITM Power Plc A large order would really set the share price off

ITM Power Plc (LON:ITM) is the topic of conversation when Dr Tom McColm talks to DirectorsTalk about the UK Government’s £23m funding for hydrogen vehicles and infrastructure. Tom talks us through the announcement, how this fits in with the company’s commercialisation effort and what we should be looking out for from in terms of news-flow […]

See More...

Ilika Plc Price drop not justified – the company is doing fine

Ilika Plc (LON:IKA)  is the topic of conversation when Dr Tom McColm talks to DirectorsTalk about the recent trading statement issued. Tom explains why the company share price has dropped as a result, his thoughts on the Bio-electronic medicine partnership with Galvani and what we should be looking out for from Ilika to drive share […]

See More...

Marshall Motor Holdings plc performing well

Marshall Motor Holdings plc (LON:MMH) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen talks to DirectorsTalk. Mike talks us through the important parts of the annual results, explains what has driven the good numbers and shares his thoughts on the company outlook and current share price.   Marshall Motor Holdings […]

See More...

Headlam Group Plc Have outperformed

Headlam Group Plc (LON:HEAD) are the topic of conversation when Zeus Capital Equity Research Director Andy Hanson caught up with us. Andy talks us through the final results for year end 31st Dec 2016, his thoughts on sustainability of the improvement in operational gearing, how cash generation is looking, special dividends and how the valuation […]

See More...

The new age of live-biotherapeutics

The new age of live-biotherapeutics is the topic of conversation when Dr Gary Waanders, Healthcare Research Director at Zeus Capital talks to DirectorsTalk. Gary explains what is driving the interest in this field, the key themes for how the Live Biotherapeutics Products will work and which companies should we be keeping an eye on. The […]

See More...

Vertu Motors Plc Look very appealing

Vertu Motors Plc (LON:VTU) are the topic of conversation when Zeus Capital head of research Mike Allen caught up with DirectorsTalk. Mike talks us through the key drivers that kept Vertu in line with expectations their current trading patterns, the forecast for the company and valuation. Vertu Motors Plc, the UK automotive retailer with a […]

See More...

ITM Power Plc Hugely significant announcement

ITM Power Plc (LON:ITM) is the topic of discussion when Zeus Capital Research Director Tom McColm caught up with DirectorsTalk to talk about the first hydrogen station to be situated on the UK’s busiest refuelling station. Tom talks us through the news, his thoughts on the future of transport, why he thinks Tesla Inc (LON:TSLA) […]

See More...

Allergy Therapeutics Plc Acarovac Sales could top $500m

Allergy Therapeutics Plc (LON:AGY) is the topic of conversation with Dr Gary Waanders Director of Healthcare Research at Zeus Capital. Since Allergy Therapeutics announced today that it has obtained approval to begin a phase I clinical trial of its Acarovac MPL vaccine in Spain, Gary explains what the product designed to do, what CTA clearance […]

See More...

Oncimmune Holdings Plc Sales growth to come from a number of directions

Oncimmune Holdings Plc (LON:ONC) is the topic of conversation when Dr Gary Waanders the Director of Healthcare Research at Zeus Capital caught up with DirectorsTalk. Gary talks us through the latest interim results, the company’s key strengths and explains what is going to drive top line growth in the next 2-3 years. Gary is an […]

See More...

Zeus Capital Upgrade forecast for Allergy Therapeutics Plc

Allergy Therapeutics Plc (LON:AGY) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary explains whats driven growth in the 6 months to Dec 31st, affects on the full year and what other things should we be focusing on for Allergy Therapeutics. Allergy […]

See More...

Elegant Hotels Group Plc Very attractive long term investment

Elegant Hotels Group Plc (LON:EHG) is the topic of discussion with Mike Allen, head of research at Zeus Capital. Mike explains his take on the 2016 results, talks about key drivers, forecasts and his valuation on the company. CEO Sunil Chatrani talks to DirectorsTalk in the second video about its management contract strategy, the rationale, Waves […]

See More...

A really important investment for Mortgage Advice Bureau (Holdings) plc

Mortgage Advice Bureau (Holdings) plc (LON:MAB1) is the topic of conversation when Zeus Capital research director caught up with DirectorsTalk. Robin explains how material is this investment of a joint venture with Mortgage port is, how MAB shareholders can monitor progress being made and but how big the opportunity and the potential shareholder value creation […]

See More...

Purplebricks Group Plc Australian business to grow faster than UK

Purplebricks Group Plc (LON:PURP) is the topic of conversation with Zeus Capital research director Robin Savage. The the hybrid estate agent providing a new way to buy, sell or let property, announced yesterday its interim results for the six months ended 31 October 2016. Robin talks about the increase in revenue, making significant profits, additional […]

See More...

ITM Power Plc – Hugely symbolic announcements

ITM Power Plc (LON:ITM) are the topic of conversation when Dr Tom McColm research director at Zeus Capital discusses the latest two announcements from the company on power-to-gas storage. Tom explains what this is exactly and how ITM’s technology and business fit in with it. ITM Power Plc designs and manufactures integrated hydrogen energy solutions […]

See More...

Watkin Jones Plc Expect PE to increase as markets appreciate visibility

Watkin Jones Plc (LON:WJG) is the topic of conversation with Andy Hansom, director of equity research at Zeus Capital. Andy explains the forward sale of two properties in terms of business and for investors, talks about the business valuation and yields. Watkin Jones PLC is a leading UK developer and constructor of multi occupancy property […]

See More...

Headlam Group Plc Expected to be more profitable going forward

Headlam Group Plc (LON:HEAD) is the topic of conversation with Andy Hanson, equity research director at Zeus Capital. Andy talks us through the latest trading statement, the impact post referendum, whats driven the upgraded figures from Zeus, Andy’s thoughts on FY17 and dividends. Following the interim results announcement on 24 August 2016, the Company has […]

See More...

Bacanora Minerals Ltd Stands apart from the pack

Bacanora Minerals Ltd (LON:BCN) are the topic of conversation when Nick Chalmers Director of Metals and Mining at Zeus Capital talks to DirectorsTalk. Nick explains why they have initiated coverage on thye company, whats driving demand growth, how other companies would fair, commercially producing from deposits, long term earning forecasts for the company, Bacanora’s market […]

See More...